GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » ROC (Joel Greenblatt) %

Nova Pharma Solutions Bhd (XKLS:03006) ROC (Joel Greenblatt) % : 940.15% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Nova Pharma Solutions Bhd ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Nova Pharma Solutions Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 940.15%.

The historical rank and industry rank for Nova Pharma Solutions Bhd's ROC (Joel Greenblatt) % or its related term are showing as below:

XKLS:03006' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -61.92   Med: 359.62   Max: 645.21
Current: 433.76

During the past 9 years, Nova Pharma Solutions Bhd's highest ROC (Joel Greenblatt) % was 645.21%. The lowest was -61.92%. And the median was 359.62%.

XKLS:03006's ROC (Joel Greenblatt) % is not ranked
in the Construction industry.
Industry Median: 17.92 vs XKLS:03006: 433.76

Nova Pharma Solutions Bhd's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Nova Pharma Solutions Bhd ROC (Joel Greenblatt) % Historical Data

The historical data trend for Nova Pharma Solutions Bhd's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Pharma Solutions Bhd ROC (Joel Greenblatt) % Chart

Nova Pharma Solutions Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only 413.17 -61.92 34.09 76.64 359.62

Nova Pharma Solutions Bhd Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.39 235.67 48.28 346.53 940.15

Competitive Comparison of Nova Pharma Solutions Bhd's ROC (Joel Greenblatt) %

For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Pharma Solutions Bhd's ROC (Joel Greenblatt) % Distribution in the Construction Industry

For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Nova Pharma Solutions Bhd's ROC (Joel Greenblatt) % falls into.



Nova Pharma Solutions Bhd ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.724 + 0 + 1.084) - (3.009 + 0 + 0.456)
=0.343

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.022 + 0 + 1.259) - (0.279 + 0 + 2.697)
=-0.695

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Nova Pharma Solutions Bhd for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=4.414/( ( (0.323 + max(0.343, 0)) + (0.273 + max(-0.695, 0)) )/ 2 )
=4.414/( ( 0.666 + 0.273 )/ 2 )
=4.414/0.4695
=940.15 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nova Pharma Solutions Bhd  (XKLS:03006) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Nova Pharma Solutions Bhd ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nova Pharma Solutions Bhd (XKLS:03006) Business Description

Traded in Other Exchanges
N/A
Address
Jalan USJ 25/1, Level 5, Suite C-5-1 & 2, Block C, Sky Park, One City, Subang Jaya, SGR, MYS, 47650
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Nova Pharma Solutions Bhd (XKLS:03006) Headlines

No Headlines